Streetbeat News

Products Services

HOTH

Hoth Therapeutics has received approval from the Montefiore Medical Center and the Dana-Farber Cancer Institute to proceed with a Phase 2a clinical trial of HT-001, targeting skin toxicities from Epidermal Growth Factor Receptor Inhibitors.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 2:37 pm

SPY

UNG

The latest report on USA natural gas storage shows an increase of 13 billion cubic feet, which is significantly lower than the estimated 26 billion cubic feet and the previous week's increase of 35 billion cubic feet.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 2:30 pm

LMT

Lockheed Martin will deliver two C-130J-30 Super Hercules tactical airlifters to the Egyptian Air Force through a Foreign Military Sale with the U.S. Air Force, as announced at the Egypt International Air Show.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 2:22 pm

AMD

Advanced Micro Devices (AMD) has seen unusual options activity, with a significant number of bullish trades. This suggests potential positive movement in AMD's stock price, with investors targeting a price range of $130 to $220. The current stock price is $141.38, up 0.36%.

Portfolio Pulse from Benzinga Insights

September 05, 2024 | 2:19 pm

BAVA.CO

The European Commission has delivered 100,000 mpox vaccine doses to the Democratic Republic of Congo, with more to follow. This is part of a larger EU initiative to combat the mpox outbreak in Africa, involving donations from multiple EU countries and coordination with the Africa CDC.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 2:19 pm

JEPI

MSFT

SPYI

The article discusses the NEOS S&P 500 High Income ETF (SPYI) as a reliable source of monthly income during unpredictable market conditions. It compares SPYI with the JPMorgan Equity Premium Income ETF (JEPI), highlighting SPYI's superior performance and tax efficiency. SPYI invests in all S&P 500 constituents and uses out-of-the-money covered call options to generate income, offering a consistent monthly distribution. In contrast, JEPI's performance and income distribution have been less stable.

Portfolio Pulse from Austin Hankwitz

September 05, 2024 | 2:16 pm

SIRI

TM

Toyota and Lexus have joined SiriusXM's new three-year Extended Service Subscription program, allowing dealerships to offer extended SiriusXM services with new vehicle purchases. This program aims to enhance customer value and flexibility in payment options.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 2:06 pm

MSFT

OpenAI is considering high-priced subscriptions for its upcoming AI models, Strawberry and Orion, with potential prices up to $2,000 per month. This pricing strategy could impact competitors like Google and Anthropic.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 2:02 pm

AAPL

PYPL

PayPal is integrating its debit card with Apple Pay and offering cashback rewards to enter the U.S. point-of-sale market. This strategic move aims to capture in-person purchases, supported by a significant marketing investment.

Portfolio Pulse from Benzinga Neuro

September 05, 2024 | 1:54 pm

BMRN

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) aims for $4 billion in revenue by 2027, focusing on three business units: skeletal conditions, enzyme therapies, and Roctavian. The company is implementing a $500 million cost transformation program to achieve a 40% operating margin by 2026. BioMarin's pipeline includes promising programs like Voxzogo, which could become a $5 billion opportunity. The company plans to launch two new products by 2027 and has updated its Roctavian strategy to focus on the U.S., Germany, and Italy.

Portfolio Pulse from Vandana Singh

September 05, 2024 | 1:51 pm